Lanzamiento Enero 2027

Metaanálisis2026Financiación no declarada

Vitamin D-containing supplementation and depressive symptom severity in adults: A Bayesian systematic review and evidence-structure assessment

Xu G, Hu T, Zhang C, Kang M, Fang Y, Jiang Y, Gao Z, Wan X, Gao B

Clinical nutrition (Edinburgh, Scotland) · 0 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Metaanálisis (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2026-08-03 · Clin Nutr · vol. 64 · pág. 106751
Editorial
Elsevier BV
Citado
0 citas · más que el 62% de estudios similares · 0.0× el promedio de su campo
Referencias
25 trabajos
Acceso
De pago
Áreas de investigación
Vitamin D Research Studies · Vitamin C and Antioxidants Research · Bipolar Disorder and Treatment
Palabras clave
Vitamin, Depressive symptoms, Vitamin D and neurology, Depression (economics), Bayesian probability
MeSH
humans, vitamin d, severity of illness index, bayes theorem, depression, dietary supplements, adult, randomized controlled trials as topic

9 autores

  • Guangru Xu🇨🇳Shanghai University of Traditional Chinese Medicine; Shuguang Hospital; Pudong New Area People's Hospital
  • Tiantian Hu
  • Chuanxia Zhang🇨🇳Pudong New Area People's Hospital
  • Mengyuan Kang🇨🇳Pudong New Area People's Hospital
  • Yuan Fang🇨🇳Anhui Medical University; Second Affiliated Hospital of Anhui Medical University
  • Yin Jiang
  • Zhiyuan Gao🇨🇳Shanghai University of Traditional Chinese Medicine; Yueyang Hospital
  • Xiaoxi Wan🇨🇳Pudong New Area People's Hospital
  • Biao Gao

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background & aims

Vitamin D supplementation has been proposed as a nutrition-related adjunctive strategy for depressive symptoms, but randomized evidence remains heterogeneous, and the feasibility of comparing multicomponent vitamin D-containing regimens is unclear. We evaluated the effects of vitamin D-containing supplementation on depressive symptom severity in adults and assessed whether the evidence structure supported network or component-level inference.

Methods

We searched PubMed, Embase, CENTRAL, ClinicalTrials.gov, and WHO ICTRP from inception to 15 April 2026. Randomized studies of vitamin D-containing nutritional interventions in adults with depressive disorders or clinically relevant depressive symptoms were included. The primary analysis was a Bayesian random-effects pairwise meta-analysis of endpoint depressive symptom scores in the oral vitamin D evidence layer. Frequentist endpoint and change-score analyses were used as robustness checks. Treatment-network connectivity and component estimability were assessed before any network or component network meta-analysis was attempted.

Results

Thirteen randomized studies published between 2013 and 2024 were retained. Seven studies with eight endpoint contrasts contributed to the Bayesian oral endpoint synthesis. Vitamin D-containing supplementation favored lower depressive symptom severity compared with comparators, with a posterior median SMD of -0.88 (95% credible interval, -1.38 to -0.35). Directional probabilities favored benefit, but between-study heterogeneity was substantial and posterior predictive intervals crossed the null. The treatment network was fragmented, and co-nutrient variation was sparse; therefore, formal network meta-analysis, treatment ranking, and component-level nutrient-synergy estimation were not methodologically defensible.

Conclusion

Vitamin D-containing supplementation shows a favorable but heterogeneous signal for depressive symptom severity in adults. Current randomized evidence supports cautious pairwise synthesis but not clinical treatment ranking or claims of incremental benefit from specific co-nutrients. Better replicated, vitamin D status-stratified, and component-informative trials are needed.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.